Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 4;21(12):e3002387.
doi: 10.1371/journal.pbio.3002387. eCollection 2023 Dec.

Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174

Guibing Liu  1 , Xiu Li  1 , Yujing Wang  1 , Xuan Zhang  1   2 , Weimin Gong  1
Affiliations

Structural basis for ligand recognition and signaling of the lysophosphatidylserine receptors GPR34 and GPR174

Guibing Liu et al. PLoS Biol. .

Abstract

Lysophosphatidylserine (LysoPS) is a naturally occurring lipid mediator involved in various physiological and pathological processes especially those related to the immune system. GPR34, GPR174, and P2Y10 have been identified as the receptors for LysoPS, and its analogues have been developed as agonists or antagonists for these receptors. However, the lack of structural information hinders the drug development with novel characteristics, such as nonlipid ligands and allosteric modulators. Here, we determined the structures of human GPR34 and GPR174 in complex with LysoPS and G protein by cryo-EM. Combined with structural analysis and functional studies, we elucidated the lipid-binding modes of these receptors. By structural comparison, we identified the structural features of GPR34 and GPR174 in active state. Taken together, our findings provide insights into ligand recognition and signaling of LysoPS receptors and will facilitate the development of novel therapeutics for related inflammatory diseases and autoimmune diseases.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Overall structures of GPR34-Gi complex and GPR174-Gs complex.
(A) Cryo-EM density map and model of GPR34-Gi complex. Density of LysoPS is shown as mesh in the middle and colored plum. (B) The map and model of ECL2 of GPR34-Gi complex (extracellular view). (C) Cryo-EM density map and model of GPR174-Gs complex. Density of LysoPS is shown as mesh in the middle and colored salmon. (D) The map and model of ECL2 of GPR174-Gs complex (extracellular view). GPR34 is colored marine green. GPR174 is colored blue. ECL2 is colored orange. Gαi, Gαs, Gβ, and Gγ subunits are colored gold, cyan, pink, and light green, respectively. ScFv16 and Nb35 are colored grey.
Fig 2
Fig 2. Recognition of LysoPS by GPR34 and GPR174.
(A) Interactions between LysoPS and GPR34. Polar interactions are depicted as black dashed lines. (B) Normalized ΔBRET of GPR34 mutants in response to 10 μM LysoPS relative to wild-type GPR34 in Gi-dissociation assays. (C) Interactions between LysoPS and GPR174. Polar interactions are depicted as black dashed lines. The π–π interaction is depicted as a red dashed line. (D) Net cAMP accumulation of CHO cells expressing GPR174 mutants in response to 10 μM LysoPS. WT-basal represents net cAMP accumulation of cells expressing wild-type GPR174 in the absence of exogenous LysoPS. Data represent mean ± SEM from 3 independent experiments. Mutants with expression less than half that of the wild-type receptor are labeled with red stars. The data used to generate graphs in Fig 2B and 2D are available in S1 Data.
Fig 3
Fig 3. Comparison of LysoPS recognition by GPR34 and GPR174.
(A) Interactions between GPR174 and the polar head of LysoPS (18:0) or LysoPS (18:1). (B) Interactions between GPR174 and the acyl tail of LysoPS (18:0) or LysoPS (18:1). The double bond of LysoPS (18:1) is colored red; the corresponding single bond in LysoPS (18:0) is colored orange. (C) Charged interactions between LysoPS and GPR34 in the positively charged pocket. (D) Charged interactions between LysoPS and GPR174 in the positively charged pocket. (E) Structural superposition of LysoPS bound GPR34 and GPR174 (extracellular view). (F) Comparison between acyl tails of LysoPS binding in GPR34 and GPR174. Polar or charged interactions are depicted as black dashed lines.
Fig 4
Fig 4. Comparison of lysophospholipid-binding modes.
The ligand-binding pockets of GPR34 (A), GPR174 (B), S1P1 (C, PDB: 7td3), LPA1 (D, PDB: 7dt0), GPR119 (E, PDB: 7xz5), and LPA6 (F, PDB: 5xsz). GPR34, GPR174, S1P1, LPA1, GPR119, and LPA6 are colored marine green, blue, dark gold, orange, plum, and light blue, respectively. The ligands are shown as sticks. The blobs represent the surface of the atomic models.
Fig 5
Fig 5. G protein coupling of GPR34 and GPR174.
(A) Structural superposition of GPR34-Gαi and rhodopsin-Gαi (PDB: 6cmo). Rhodopsin is colored pink, and Gi coupled to it is colored cyan. (B) Structural superposition of GPR34-Gαi and CB2-Gαi (PDB: 6pt0). CB2 is colored brown, and Gαi coupled to it is colored cyan. The displacements are indicated by arrows. (C) Interactions between the C terminus of α5 and GPR34. (D) Interactions between α5/β6 of Gαi and ICL3 of GPR34. (E) Relative intrinsic activity (RAi) plot of GPR34 mutants of the G protein–coupling sites in Gi-dissociation assays. RAi was calculated as [Emax(test)/EC50(test)]/[Emax(WT)/EC50(WT)]. Emax and EC50 are from the averaged concentration-response curves of 3 independent experiments. (F) Superposition of GPR174-Gαs, β2AR-Gαs (PDB: 3sn6), and CCKAR-Gαs (PDB: 7ezk). GPR174, β2AR, and CCRKAR are colored blue, light yellow, and magenta, respectively. Gαs subunits in these structures are colored light blue, yellow, and plum, respectively. (G) Interactions between the C terminus of α5 helix and GPR174. (H) Interactions between Gαs and ICL3 of GPR174. (I) Interactions between Gαs and ICL2 of GPR174. Polar interactions are depicted as black dashed lines. (J) Basal activity and maximal LysoPS-induced activity of GPR174 mutants in cAMP accumulation assays. Data are from the averaged concentration-response curves of 3 independent experiments. The data used to generate graphs in Fig 5E and 5J are available in S1 Data.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Makide K, Uwamizu A, Shinjo Y, Ishiguro J, Okutani M, Inoue A, et al.. Novel lysophosphoplipid receptors: their structure and function. J Lipid Res. 2014;55(10):1986–1995. Epub 2014/06/04. doi: 10.1194/jlr.R046920 ; PubMed Central PMCID: PMC4173991. - DOI - PMC - PubMed
    1. Yanagida K, Valentine WJ. Druggable lysophospholipid signaling pathways. Adv Exp Med Biol. 2020;1274:137–176. Epub 2020/09/08. doi: 10.1007/978-3-030-50621-6_7 . - DOI - PubMed
    1. Lee SY, Lee HY, Kim SD, Jo SH, Shim JW, Lee HJ, et al.. Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells. Biochem Biophys Res Commun. 2008;374(1):147–151. Epub 2008/07/12. doi: 10.1016/j.bbrc.2008.06.117 . - DOI - PubMed
    1. Park KS, Lee HY, Kim MK, Shin EH, Jo SH, Kim SD, et al.. Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins. Mol Pharmacol. 2006;69(3):1066–1073. Epub 2005/12/22. doi: 10.1124/mol.105.018960 . - DOI - PubMed
    1. Lourenssen S, Blennerhassett MG. Lysophosphatidylserine potentiates nerve growth factor-induced differentiation of PC12 cells. Neurosci Lett. 1998;248(2):77–80. Epub 1998/07/08. doi: 10.1016/s0304-3940(98)00275-4 . - DOI - PubMed

MeSH terms

LinkOut - more resources